Barentz appoints Daniel Hitz as CEO, APAC
Hitz shall assume new role from January 17th, 2022
Hitz shall assume new role from January 17th, 2022
He has over 22 years of experience in pharmaceutical sales & business development
Since its launch, the medical devices park in Sultanpur has received overwhelming response with more than 50 companies lining up to set up their manufacturing or research and development units
The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)
The campaign “Care is Just An Aster Away” was launched along with the unveiling of the new corporate logo on Burj Khalifa on 11th December
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
The aim is to support Pharmacovigilance programme across the countries in the region
The workshop had been organized by the department of surgery at Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), along with the Association of Surgeons of Aligarh (ASA)
Subscribe To Our Newsletter & Stay Updated